|
RPRD1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.423800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.960300E-02 |
| Normal-vs-Stage2 |
7.090000E-01 |
| Normal-vs-Stage3 |
4.190800E-01 |
| Normal-vs-Stage4 |
1.012570E-01 |
| Stage1-vs-Stage2 |
6.162000E-01 |
| Stage1-vs-Stage3 |
9.353000E-01 |
| Stage1-vs-Stage4 |
6.157000E-01 |
| Stage2-vs-Stage3 |
7.494400E-01 |
| Stage2-vs-Stage4 |
4.089400E-01 |
| Stage3-vs-Stage4 |
5.557000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.162400E-01 |
| Normal-vs-AfricanAmerican |
3.016400E-02 |
| Normal-vs-Asian |
2.599500E-03 |
| Caucasian-vs-AfricanAmerican |
1.995240E-01 |
| Caucasian-vs-Asian |
4.085700E-02 |
| AfricanAmerican-vs-Asian |
2.759000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.653900E-02 |
| Normal-vs-Female |
9.731000E-01 |
| Male-vs-Female |
2.472000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.977600E-02 |
| Normal-vs-Extreme_Weight |
1.123750E-02 |
| Normal-vs-Obese |
7.798800E-01 |
| Normal-vs-Extreme_Obese |
9.998500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.083000E-01 |
| Normal_Weight-vs-Obese |
2.220600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.804600E-01 |
| Extreme_Weight-vs-Obese |
9.953500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.844000E-01 |
| Obese-vs-Extreme_Obese |
1.739620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.859600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.644200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.355900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.196700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.855400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.561800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.071960E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.195800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.499500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.585200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.656400E-01 |
| Normal-VS-Type2 PRCC |
5.52729999999668E-05 |
| Normal-VS-KIRP CIMP |
9.644200E-01 |
| Normal-VS-Unclassified PRCC |
4.464200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.016200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.208000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.173800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.955800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.241700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.215800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.201500E-03 |
| Normal-vs-N1 |
8.249400E-01 |
| Normal-vs-N2 |
3.161600E-01 |
| N0-vs-N1 |
6.263900E-02 |
| N0-vs-N2 |
9.536800E-01 |
| N1-vs-N2 |
4.702200E-01 |
|
|
